眼科用药物递输系统的全球市场-产业分析，规模，占有率，成长，趋势，2022年～2028年前的预测

Value Market Research深入调查眼科用药物递输系统的全球市场，并预测未来几年行业将出现显着增长。本研究报告提供全球眼科用药物递输系统市场相关之完全产业分析，提供市场规模、市场占有率、增长趋势、2023年至2028年的预测等。该报告以详细的市场介绍和突出报告关键增长数据的执行摘要为首。接续的章节讨论市场价值链、波特五力模型和市场吸引力分析。同时还设立关于COVID-19影响分析的独立章节，以了解市场如何应对疫情。

本报告的市场动态部分详细介绍了当前的市场推动因素/阻碍、课题/风险和未来机遇。本节对企业战略家和新产品开发部门非常有用。眼科用药物递输系统全球市场调查将市场细分化，并根据收益和/或销售额的视点提供市场规模。该数据按地区细分，同时按国家/地区细分。数据是通过深入的初级访谈和世界各地的行业专家收集而来。详细的调查方法可以在样本报告中找到。这些市场预测受到最新的社会、政治和经济变化以及影响该眼科用药物递输系统市场的当前市场动态所影响。

眼科用药物递输系统市场报告的子章节提供市场竞争力调查，提供一些领先的市场参与者/製造商简介。这些章节涵括可深入了解竞争对手的产品线、财务状况、最新发展以及在行业中拥有最高市场占有率公司所需的丰富资讯。

本报告的观察对象国家如下列。

北美:美国，加拿大，墨西哥

欧洲:英国，德国，法国，义大利，俄罗斯，西班牙，其他欧洲各国

亚太地区:中国，印度，日本，韩国，澳洲，其他APAC的其他各国

南美:巴西，阿根廷，秘鲁，智利，其他南美国家地区

中东·非洲地区:沙乌地阿拉伯，UAE，以色列，南非

本报告的市场区隔如下列。

各技术

局部麻醉

离子电渗疗法(眼用植入剂(Erodible and Non-Erodible), and 人工晶状体(Biodegradable and Non-Biodegradable))

原位凝胶和泪管塞

其他

各製剂类型

微脂体·奈米粒子

溶液

乳胶

悬浮液

软膏

各疾病

青光眼

糖尿病视网膜病变

干眼症症候群

黄斑部病变

白内障

糖尿病黄斑部水肿

其他

各终端用户

医院

眼科诊所

外科门诊诊疗所(ASC)

居家医疗

目录

第1章 序文

• 本报告的内容
  • 目的
  • 主要读者
  • 独特的销售主张(USP)和报价环
• 调查范围
• 调查手法
  • 市场调查流程
  • 市场调查手法

第2章 摘要整理

• 市场概况
• 全球市场概述

第3章 眼科用药物递输系统- 产业分析

• 简介- 市场动态
• 推动市场要素
• 阻碍市场要素
• 商机
• 产业趋势
• 波特的五力分析
• 市场魅力分析
  • 各技术
  • 各製剂类型
  • 各疾病类型
  • 各终端用户
  • 各地区

第4章 价值链分析

• 价值链分析
• 原料的分析
  • 原料的清单
  • 原料的製造原清单
  • 主要原料的价格趋势
• 潜在的买主清单
• 销售管道
  • 直销
  • 间接行销
  • 行销流通管道的开发趋势

第5章 COVID-19发生的影响分析

• 各COVID-19发生影响分析
  • 对生产的直接性影响
  • 供应链与市场的混乱
  • 对企业及金融市场的财务的影响
• COVID-19生产，进口，出口，各需求的影响分析
• 市场COVID-19发生前/发生后
• 冠状病毒(COVID-19)流行的影响预测
• COVID-19:微观和宏观的要素分析

第6章 眼科用药物递输系统的全球市场:各技术分析

• 各技术概要
• 实际成果资料与预测资料
• 各技术分析
• 外用药市场:各地区
• 离子电渗疗法各地区市场
• 眼部插入镜头市场:各地区
• 眼内植入的各地区市场
• insaichugeru和放炮桶插头的各地区市场
• 其他的各地区市场

第7章 眼科用药物递输系统的全球市场:各製剂类型分析

• 各製剂类型概要
• 实际成果资料与预测资料
• 各製剂类型分析
• 微脂体·奈米粒子各地区市场
• 溶液的各地区市场
• 乳胶的各地区市场
• 悬浮液的各地区市场
• 软膏的各地区市场

第8章 眼科用药物递输系统的全球市场分析:各疾病类型

• 各疾病类型概要
• 实际成果资料与预测资料
• 各疾病类型分析
• 青光眼的各地区市场
• 糖尿病视网膜病变各地区市场
• 干眼症症候群的各地区市场
• 黄斑部病变的各地区市场
• 白内障的各地区市场
• 糖尿病黄斑部水肿的各地区市场
• 其他各地区市场

第9章 眼科用药物递输系统的全球市场分析(各终端用户

• 各终端用户概要
• 实际成果资料与预测资料
• 各终端用户分析
• 医院各地区市场
• 眼科诊所的各地区市场
• 外科门诊诊疗所的各地区市场(ASC
• 家庭看护的各地区市场

第10章 眼科用药物递输系统的全球市场:各地区分析

• 各地区展望
• 简介
• 北美
  • 概要，历史的资料，预测资料
  • 北美:各市场区隔
  • 北美各国资料
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 概要，过去实际成果与预测资料
  • 欧洲:各市场区隔
  • 欧洲的各国资料
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他的欧洲地区
• 亚太地区
  • 概要，过去实际成果与预测资料
  • 亚太地区:各市场区隔
  • 亚太地区各国资料
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 其他亚太地区
• 南美
  • 概要，过去实际成果与预测资料
  • 南美:各市场区隔
  • 南美:各国资料
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他的南美地区
• 中东·非洲地区
  • 概要，过去实际成果与预测资料
  • 中东·非洲:各市场区隔
  • 中东·非洲地区各国资料
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他的中东·非洲地区

第11章 眼科用药物递输系统企业的竞争情形

• 眼科用药物递输系统市场竞争
• 伙伴关係/合作/契约
• 合併·收购
• 新产品上市
• 其他的开发

第12章 企业简介

• 企业占有率分析
• 市场集中度
• Taiwan Liposome Company, Ltd.
  • 企业概要
  • 产品介绍
  • 最近的开发情形
• Valeant Pharmaceuticals International, Inc.
  • 公司概要
  • 产品介绍
  • 最近的开发情形
• Ocular Therapeutix, Inc.
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Graybug Vision Inc.
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Clearside Biomedical, Inc.
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• EyeGate Pharma
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Envisia Therapeutics
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Alimera Sciences
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Allergan Plc
  • 公司概要
  • 产品资讯
  • 最新资讯

在企业简介中，财务内容和最近的开发情形，可取得的资讯基于，有是非上市公司的情况没被刊载的可能性。

Value Market Research deeply researched the Global Ocular Drug Delivery System Market to foresee a significant growth in the industry over the upcoming years. The global ocular drug delivery system market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global ocular drug delivery system market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this ocular drug delivery system market.

The next sections of the ocular drug delivery system market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America - United States, Canada, and Mexico

Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC

Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below-

By Technology

Topical

Iontophoresis (Ocular Insert(Erodible and Non-Erodible), and Intraocular Implants(Biodegradable and Non-Biodegradable)

In Situ Gel & Punctal Plugs

Others

By Formulation Type

Liposomes & Nanoparticles

Solution

Emulsion

Suspension

Ointment

By Disease Type

Glaucoma

Diabetic Retinopathy

Dry Eye Syndrome

Macular Degeneration

Cataract

Diabetic Macular Edema

Others

By End Users

Hospitals

Ophthalmic Clinics

Ambulatory Surgical Centers

Homecare Settings

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . OCULAR DRUG DELIVERY SYSTEM - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 By Technology
  • 3.7.2 By Formulation Type
  • 3.7.3 By Disease Type
  • 3.7.4 By End Users
  • 3.7.5 By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

• 5.1. Impact Analysis of Covid-19 Outbreak
  • 5.1.1. Direct Impact on Production
  • 5.1.2. Supply Chain and Market Disruption
  • 5.1.3. Financial Impact on Firms and Financial Markets
• 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
• 5.3. Market: Pre V/S Post COVID-19
• 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
• 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL OCULAR DRUG DELIVERY SYSTEM MARKET ANALYSIS BY TECHNOLOGY

• 6.1 Overview by Technology
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Technology
• 6.4 Topical Market by Regions
• 6.5 Iontophoresis Market by Regions
• 6.6 Ocular Insert Market by Regions
• 6.7 Intraocular Implants Market by Regions
• 6.8 In Situ Gel & Punctal Plugs Market by Regions
• 6.9 Others Market by Regions

7 . GLOBAL OCULAR DRUG DELIVERY SYSTEM MARKET ANALYSIS BY FORMULATION TYPE

• 7.1 Overview by Formulation Type
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Formulation Type
• 7.4 Liposomes & Nanoparticles Market by Regions
• 7.5 Solution Market by Regions
• 7.6 Emulsion Market by Regions
• 7.7 Suspension Market by Regions
• 7.8 Ointment Market by Regions

8 . GLOBAL OCULAR DRUG DELIVERY SYSTEM MARKET ANALYSIS BY DISEASE TYPE

• 8.1 Overview by Disease Type
• 8.2 Historical and Forecast Data
• 8.3 Analysis by Disease Type
• 8.4 Glaucoma Market by Regions
• 8.5 Diabetic Retinopathy Market by Regions
• 8.6 Dry Eye Syndrome Market by Regions
• 8.7 Macular Degeneration Market by Regions
• 8.8 Cataract Market by Regions
• 8.9 Diabetic Macular Edema Market by Regions
• 8.10. Others Market by Regions

9 . GLOBAL OCULAR DRUG DELIVERY SYSTEM MARKET ANALYSIS BY END USERS

• 9.1 Overview by End Users
• 9.2 Historical and Forecast Data
• 9.3 Analysis by End Users
• 9.4 Hospitals Market by Regions
• 9.5 Ophthalmic Clinics Market by Regions
• 9.6 Ambulatory Surgical Centers Market by Regions
• 9.7 Homecare Settings Market by Regions

10 . GLOBAL OCULAR DRUG DELIVERY SYSTEM MARKET ANALYSIS BY GEOGRAPHY

• 10.1. Regional Outlook
• 10.2. Introduction
• 10.3. North America
  • 10.3.1. Overview, Historic and Forecast Data
  • 10.3.2. North America By Segment
  • 10.3.3. North America By Country
  • 10.3.4. United State
  • 10.3.5. Canada
  • 10.3.6. Mexico
• 10.4. Europe
  • 10.4.1. Overview, Historic and Forecast Data
  • 10.4.2. Europe by Segment
  • 10.4.3. Europe by Country
  • 10.4.4. United Kingdom
  • 10.4.5. France
  • 10.4.6. Germany
  • 10.4.7. Italy
  • 10.4.8. Russia
  • 10.4.9. Rest Of Europe
• 10.5. Asia Pacific
  • 10.5.1. Overview, Historic and Forecast Data
  • 10.5.2. Asia Pacific by Segment
  • 10.5.3. Asia Pacific by Country
  • 10.5.4. China
  • 10.5.5. India
  • 10.5.6. Japan
  • 10.5.7. South Korea
  • 10.5.8. Australia
  • 10.5.9. Rest Of Asia Pacific
• 10.6. Latin America
  • 10.6.1. Overview, Historic and Forecast Data
  • 10.6.2. Latin America by Segment
  • 10.6.3. Latin America by Country
  • 10.6.4. Brazil
  • 10.6.5. Argentina
  • 10.6.6. Peru
  • 10.6.7. Chile
  • 10.6.8. Rest of Latin America
• 10.7. Middle East & Africa
  • 10.7.1. Overview, Historic and Forecast Data
  • 10.7.2. Middle East & Africa by Segment
  • 10.7.3. Middle East & Africa by Country
  • 10.7.4. Saudi Arabia
  • 10.7.5. UAE
  • 10.7.6. Israel
  • 10.7.7. South Africa
  • 10.7.8. Rest Of Middle East And Africa

11 . COMPETITIVE LANDSCAPE OF THE OCULAR DRUG DELIVERY SYSTEM COMPANIES

• 11.1. Ocular Drug Delivery System Market Competition
• 11.2. Partnership/Collaboration/Agreement
• 11.3. Merger And Acquisitions
• 11.4. New Product Launch
• 11.5. Other Developments

12 . COMPANY PROFILES OF OCULAR DRUG DELIVERY SYSTEM INDUSTRY

• 12.1. Company Share Analysis
• 12.2. Market Concentration Rate
• 12.3. Taiwan Liposome Company, Ltd.
  • 12.3.1. Company Overview
  • 12.3.2. Financials
  • 12.3.3. Products
  • 12.3.4. Recent Developments
• 12.4. Valeant Pharmaceuticals International, Inc.
  • 12.4.1. Company Overview
  • 12.4.2. Financials
  • 12.4.3. Products
  • 12.4.4. Recent Developments
• 12.5. Ocular Therapeutix, Inc.
  • 12.5.1. Company Overview
  • 12.5.2. Financials
  • 12.5.3. Products
  • 12.5.4. Recent Developments
• 12.6. Graybug Vision Inc.
  • 12.6.1. Company Overview
  • 12.6.2. Financials
  • 12.6.3. Products
  • 12.6.4. Recent Developments
• 12.7. Clearside Biomedical, Inc.
  • 12.7.1. Company Overview
  • 12.7.2. Financials
  • 12.7.3. Products
  • 12.7.4. Recent Developments
• 12.8. EyeGate Pharma
  • 12.8.1. Company Overview
  • 12.8.2. Financials
  • 12.8.3. Products
  • 12.8.4. Recent Developments
• 12.9. Envisia Therapeutics
  • 12.9.1. Company Overview
  • 12.9.2. Financials
  • 12.9.3. Products
  • 12.9.4. Recent Developments
• 12.10. Alimera Sciences
  • 12.10.1. Company Overview
  • 12.10.2. Financials
  • 12.10.3. Products
  • 12.10.4. Recent Developments
• 12.11. Allergan Plc
  • 12.11.1. Company Overview
  • 12.11.2. Financials
  • 12.11.3. Products
  • 12.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• COVID-19 Impact Analysis by Production, Import, Export and Demand
• Pre V/S Post COVID-19
• Estimated Impact Of The Coronavirus (Covid-19) Epidemic
• COVID-19: Micro and Macro Factor Analysis
• Analysis by Technology (USD MN)
• Topical Market by Geography (USD MN)
• Iontophoresis Market by Geography (USD MN)
• Ocular Insert Market by Geography (USD MN)
• Intraocular Implants Market by Geography (USD MN)
• In Situ Gel & Punctal Plugs Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Analysis Market by Formulation Type (USD MN)
• Liposomes & Nanoparticles Market by Geography (USD MN)
• Solution Market by Geography (USD MN)
• Emulsion Market by Geography (USD MN)
• Suspension Market by Geography (USD MN)
• Ointment Market by Geography (USD MN)
• Analysis by Disease Type (USD MN)
• Glaucoma Market by Geography (USD MN)
• Diabetic Retinopathy Market by Geography (USD MN)
• Dry Eye Syndrome Market by Geography (USD MN)
• Macular Degeneration Market by Geography (USD MN)
• Cataract Market by Geography (USD MN)
• Diabetic Macular Edema Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Analysis by End Users (USD MN)
• Hospitals Market by Geography (USD MN)
• Ophthalmic Clinics Market by Geography (USD MN)
• Ambulatory Surgical Centers Market by Geography (USD MN)
• Homecare Settings Market by Geography (USD MN)
• Global Ocular Drug Delivery System Market by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisiton

LIST OF FIGURES

• Research Scope of Ocular Drug Delivery System Report
• Market Research Process
• Market Research Methodology
• Global Ocular Drug Delivery System Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Technology
• Market Attractiveness Analysis by Formulation Type
• Market Attractiveness Analysis by Disease Type
• Market Attractiveness Analysis by End Users
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Technology (USD MN)
• Topical Market by Geography (USD MN)
• Iontophoresis Market by Geography (USD MN)
• Ocular Insert Market by Geography (USD MN)
• Intraocular Implants Market by Geography (USD MN)
• In Situ Gel & Punctal Plugs Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Global Market Analysis by Formulation Type (USD MN)
• Liposomes & Nanoparticles Market by Geography (USD MN)
• Solution Market by Geography (USD MN)
• Emulsion Market by Geography (USD MN)
• Suspension Market by Geography (USD MN)
• Ointment Market by Geography (USD MN)
• Global Market Analysis by Disease Type (USD MN)
• Glaucoma Market by Geography (USD MN)
• Diabetic Retinopathy Market by Geography (USD MN)
• Dry Eye Syndrome Market by Geography (USD MN)
• Macular Degeneration Market by Geography (USD MN)
• Cataract Market by Geography (USD MN)
• Diabetic Macular Edema Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Global Market Analysis by End Users (USD MN)
• Hospitals Market by Geography (USD MN)
• Ophthalmic Clinics Market by Geography (USD MN)
• Ambulatory Surgical Centers Market by Geography (USD MN)
• Homecare Settings Market by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Company Market Share Analysis
• Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.